Skip Ribbon Commands
Skip to main content

DBBS

:

Events : AVB-500, a selective inhibitor of GAS6-AXL, in combination with Paclitaxel, improves therapeutic efficacy compared to Paclitaxel alone through the alteration of endometrial cancer cell metabolism

Export Event

Requestor

Charlene Lomax

Requestor Department

Center for Reproductive Health Sciences

Requestor Phone

3142861775

Requestor Email

charlenelomax@wustl.edu

Type of Event

Scientific Seminar

Type of Lecture

Seminar Series

Start Time

5/7/2021 9:00 AM

End Time

5/7/2021 10:00 AM

Recurrence

 

All Day Event

 

Sponsoring Department/Group

Center for Reproductive Health Sciences

Speaker/Honorific

Shaina Bruce, MD

Speaker Affiliation

Clinical Fellow, Gynecologic Oncology

Title

AVB-500, a selective inhibitor of GAS6-AXL, in combination with Paclitaxel, improves therapeutic efficacy compared to Paclitaxel alone through the alteration of endometrial cancer cell metabolism

Add More Speakers (Optional)

Yes

2nd Speaker/Honorific

Elizabeth Stock, MD

2nd Speaker Affiliation

Clinical Fellow, Gynecologic Oncology

2nd Title

Increasing sensitivity to olaparib through inhibition of Discoidin Domain Receptor 2 (DDR2) in homologous-recombination proficient ovarian cancer models.

3rd Speaker/Honorific

 

3rd Speaker Affiliation

 

3rd Title

 

4th Speaker/Honorific

 

4th Speaker Affiliation

 

4th Title

 

Location

Zoom

Comments

https://zoom.us/j/350689015

Submit Another Request

No

Cancel Event

No

Career/Professional Development

No

PostdocEvent

No

Sponsor/Location

Center for Reproductive Health Sciences -
Location:  Zoom

Speaker/Title

Shaina Bruce, MD  -
AVB-500, a selective inhibitor of GAS6-AXL, in combination with Paclitaxel, improves therapeutic efficacy compared to Paclitaxel alone through the alteration of endometrial cancer cell metabolism

Sponsor/Speaker/Title/Location

Center for Reproductive Health Sciences -
Location:  Zoom -
Shaina Bruce, MD  -
AVB-500, a selective inhibitor of GAS6-AXL, in combination with Paclitaxel, improves therapeutic efficacy compared to Paclitaxel alone through the alteration of endometrial cancer cell metabolism

start

5/7/2021

ShowOnHomePage

No

Approved Event

Yes

iCal

http://dbbs.wustl.edu/_vti_bin/owssvr.dll?CS=109&Cmd=Display&List={3C2772E8-70D9-4EF9-BB74-B38E64DFF302}&CacheControl=1&ID=&Using=event.ics

Attachments

Content Type: Event
Created at 4/27/2021 3:17 PM by  
Last modified at 4/28/2021 10:01 AM by Andrew Richards